[1] S. S. Swain and D. Dude, Anti-dengue medicinal plants: a mini review. Res. Rev. J Pharmacogn Phytochem., 1 (2013) 5-9.
[2] M. E. Beatty, A. Stone, W. D. Fitzsimons, J. N. Hanna, S. K. Lam and S. Vong, Best practices in dengue surveillance: a report from the Asia-Pacific and Americas Dengue Prevention Boards. PLoS. Negl. Trop. Dis., 4 (2010) 890.
[3] Z. Fatima, M. Idrees, M. A. Bajwa, Z. Tahir, O. Ullah and M.Q. Zia, Serotype and genotype analysis of dengue virus by sequencing followed by phylogenetic analysis using samples from three mini outbreaks-2007-2009 in Pakistan. BMC Microbiol., 11 (2011)200.
[4] J. A. Ayukekbong, O. G. Oyero, S. E. Nnukwu, H. N. Mesumbe and C.N. Fobisong, Value of routine dengue diagnosis in endemic countries. World. J. Virol., 6 (2017) 9-16.
[5] C. Nitsche, S. Holloway, T. Schirmeister and C. D. Klein, Biochemistry and medicinal chemistry of the dengue virus protease. Chem Rev., 114 (2014) 11348–11381.
[6] A. J. Stevens, M. E. Gahan, S. Mahalingam and P. A. Keller, The medicinal chemistry of dengue fever. J. Med. Chem., 52 (2009) 7911–7926.
[7] S. P. Lim, Q. Y. Wang, C. G. Noble, Y. L. Chen, H. Dong, B. Zou, F. Yokokawa, S. Nilar, P. Smith, D. Beer, J. Lescar and P. Y. Shi, Ten years of dengue drug discovery: Progress and prospects. Antiviral Res., 100 (2013) 500–519.
[8] A. E. Sahili and J. Lescar, Dengue Virus Non-Structural Protein 5. Viruses., 9 (2017) 9.
[9] J. Lei, G. Hansen, C. Nitsche, C. D. Klein, L. Zhang and R. Hilgenfeld. The Crystal structure of Zika virus NS2B-NS3 protease in complex with a boronate inhibitor. Sci., 353 (2016) 503−505.
[10] C. Nitsche, L. Zhang, L. F. Weigel, J. Schilz, D. Graf, R. Bartenschlager, R. Hilgenfeld and C. D. Klein, Peptide–boronic acid inhibitors of flaviviral proteases: Medicinal chemistry and structural biology. J. Med. Chem., 60 (2017) 511−516.
[11] J. Suganya and R. Mahendran. Molecular docking studies of selected medicinal plant compounds against NS5 and NS3 protein of dengue virus: a comparative approach. Int. J. Pharm. Bio. Sci., 7 (2016) 1135 – 1144.
[12] Y. Yao, T. Huo, Y. Lin, S. Nie, F. Wu, Y. Hua, J. Wu, A. R. Kneubehl, M. B. Vogt, R. Rico-Hesse and Y. Song,
Discovery, X-ray crystallography and antiviral activity of allosteric inhibitors of flavivirus NS2B-NS3 protease. J. Am. Chem. Soc., 141 (2019) 6832-36.
[13] W. Schul, W. Liu, H. Y. Xu, M. Flamand and S. G. Vasudevan, A dengue fever viremia model in mice show a reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs. J. Infect. Dis.,195 (2007) 665-674.
[14] W. J. Kassler, P. Blanc and R. Greenblatt, The use of medicinal herbs by human immunodeficiency virus-infected patients. Arch. Intern. Med., 151 (1991) 2281-2288.
[15] H. C. Ko, B. L. Wei and W. F. Chiou, The effect of medicinal plants used in Chinese folk medicine on RANTES secretion by virus-infected human epithelial cells. J. Ethnopharmacol., 107, (2006) 205-210.
[16] L. T. Lin, W. C. Hsu and C. C. Lin, Antiviral natural products and herbal medicines. J. Tradit. Complement. Med., 4 (2014) 24-35.
[17] S. L. Woodward and J. A. Quinn, Encyclopedia of Invasive Species: From Africanized Honey Bees to Zebra Mussels, Greenwood Publishing Group, Santa Barbara, CA, USA, 1. 2011.
[18] B. Gao, J. Zhang and L. Xie, Structure analysis of effective chemical compounds against dengue viruses isolated from I. tinctoria. Can. J. Infect. Dis. Med. Microbiol., 2018 https://doi.org/10.1155/2018/3217473.
[19] W. J. Hehre and W. W. Huang, Chemistry with Computation: An introduction to SPARTAN, Wavefunction, Inc; 1995.
[20] Z. Li, H. Wan, Y. Shi and P. Ouyang, Personal experience with four kinds of chemical structure drawing software: a review on ChemDraw, ChemWindow, ISIS/Draw, and ChemSketch. J. Chem. Inform. Comput. Sci., 44 (2004) 1886-1890.
[21] E. R. Davidson and D. Feller, Basis set selection for molecular calculations. Chem. Rev., 86 (1986) 681-696.
[22] A. Schäfer, H. Horn and R. Aldrichs, Fully optimized contracted Gaussian basis sets atoms Li to Kr. The Journal of Chemical Physics, 97 (1992) 2571-2577.
[23] A. El Sahili, T. S. Soh, J. Schiltz, A. Gharbi-Ayachi, C. C. She, P. Y. Shi and J. Lescar, NS5 from dengue virus serotype 2 can adopt a conformation analogous to that of its zika virus and Japanese encephalitis virus homologues. J. Virol., 94 (2019) e01294-19.
[24] M. A. Neves, M. Totrov and R. Abagyan, Docking and scoring with ICM: the benchmarking results and strategies for improvement. J. Comput. Aided Mol. Des., 26 (2012) 675-86.
[25] J. Joubert, E. B. Foxen and S. F. Malan, Microwave optimized synthesis of N-(adamantan-1-yl)-4-[(adamantan-1-yl)-sulfamoyl] benzamide and its derivatives for anti-dengue virus activity. Molecules., 23 (2018) 1678.
[26] K. Zandi, R. Lani, P. E. Wong, B. T. Teoh, S. S. Sam, J. Johari, M. R. Mustafa, S. Abubakar, Flavone enhances dengue virus type-2 (NGC strain) infectivity and replication in Vero cells. Molecules., 17 (2012) 2437-2445.
[27] K. Zandi, B. T. Teoh, S. S. Sam, P. F. Wong, M. R. Mustafa, S. Abubakar, Novel antiviral activity of baicalein against dengue virus. BMC. Complement. Altern. Med., 12 (2012) 214.
[28] Ahn HC, Lee SY, Kim JW, Son WS, Shin CG, Lee BJ. Binding aspects of baicalein to HIV-1 intergrase. Mol. Cells., 12 (2001) 127-130.